“The global cosmetic market is seeking natural solutions to replace existing synthetic ingredients,” the companies say in a press statement. “As the natural cosmetics segment continues to grow, the demand for such ingredients will grow with it.”
The pact will benefit from Deinove’s know-how in leveraging the properties of its collection of rare microorganisms. The Memorandum of Understanding is expected to be finalized by the end of the quarter and has an initial term of three years. It includes payment for significant milestones, royalties on sales once commercialized, and an upfront $200,000 payment by Sharon Laboratories.